经验总结

  1. 首页 > 生活杂烩 > 美容减肥 > >

消息资讯SCI期刊投稿 | 专刊 "Hypersensitivity to Drugs and Vaccines"

drugsinjuryimmuneissueSpecial专刊toasforpaperstheand&quot

Special Issue "Hypersensitivity to Drugs and Vaccines: Molecular Basis and Translational Research"
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 August 2022
01
Special Issue Editors
消息资讯SCI期刊投稿 | 专刊 "Hypersensitivity to Drugs and Vaccines"
文章图片

02
Special Issue Information
Dear Colleagues,
Hypersensitivity to drugs and vaccines resulting from interactions between a pharmacologic component and the human immune system is an important clinical issue to be resolved. The manifestations of hypersensitive reactions range from milder skin reactions (e.g., urticaria, angioedema, or maculopapular exanthema) to multiple organ injury or severe systemic reactions. Some life-threatening examples include drug-induced liver injury (DILI), myocarditis, vasculitis, anaphylaxis, immune thrombotic thrombocytopenia, drug reactions with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS), and Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). These diverse clinical manifestations not only make diagnosis and management more challenging, but also hinder public health interventions, in particular, the currently widespread vaccination against COVID-19 to control the pandemic. Hypersensitivity reactions usually involve molecular interactions between immune repertoires (e.g., antibodies, T cell receptor (TCR)) and drugs/metabolites or components of vaccines. New approaches and technologies have been emerging and applied to discover the genetic susceptibility, predisposing factors, biomarkers, and molecular mechanisms of hypersensitivity reactions to drugs, as well as vaccines. This Special Issue of Biomedicines aims to include research on the molecular aspects, immunological features, diagnostic tools, methods of prevention, and treatment strategies for hypersensitivity to drugs and vaccines. All the basic studies and translational research, including original articles or reviews of pharmacogenomics, immune repertoire, immune epitope identification, transcriptome, metagenomics, and immunopathogenesis, will be considered.
Prof. Dr. Shuen-Iu Hung
Prof. Dr. Wen-Hung Chung
Prof. Dr. Bruce Carleton
Prof. Dr. Elizabeth J. Phillips
Guest Editors
Manuscript Submission Information
Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
03
Keywords

上一篇：成膜好用的防晒霜有哪些 防晒霜的正确涂抹方法

下一篇：因为栖桐国际：爱美没界限，请放肆爱美吧~